Comparison of the outcomes of cubital fistulas with and without perforating vein ligation

A comparative study of the outcomes of cubital fistulas with and without perforating vein ligation in hemodialysis patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240228061124N2

Enrollment

Registered

2025-10-26

Start date

2025-10-23

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outcomes of cubital fistulas in hemodialysis patients.

Interventions

Intervention 1: Ligation of the perforating vein during creation of a cubital side-to-side arteriovenous fistula. Intervention 2: Non-Ligation of the perforating vein during creation of a cubital side

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: all patients on hemodialysis who under go creation of cubital fistula in Imam Khomeini hospital of urmia

Exclusion criteria

Exclusion criteria: history of perforating vein ligation

Design outcomes

Primary

Measure	Time frame
Time to fistula maturation. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.;Number of matured veins. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.;Venous hypertension and ulcer formation. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.;Steal syndrome. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.;Dialysis adequacy. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.	—

Measure

Time frame

Time to fistula maturation. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.;Number of matured veins. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.;Venous hypertension and ulcer formation. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.;Steal syndrome. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.;Dialysis adequacy. Timepoint: First day, one week, one month, three months, and six months after AVF creation. Method of measurement: Clinical examination.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bahman Alinezhad

Oroumia University of Medical Sciences

alinezhad.b@umsu.ac.ir+98 44 3346 9939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026